• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Lumeris Secures $100M to Expand Proven Value-Based Care Solutions

by Syed Hamza Sohail 04/22/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

–              St. Louis-based, privately held Lumeris announced the completion of a $100M equity capital raise.

–              The funding round was led by Deerfield Management, a longstanding lender, and new investor Endeavor Health. Existing investors Kleiner Perkins, Sandbox Industries, BlueCross BlueShield Venture Partners and JDLinx (an investment company owned by John Doerr) participated in the round.

Advancing Value-Based Care: Lumeris’ Decade of Excellence and Future Commitments


For over a decade, Lumeris has been at the forefront of delivering exceptional value-based care outcomes for healthcare providers and their patients. This infusion of new capital underscores the commitment to supporting the rapid expansion of Lumeris’ provider partnerships, which now include some of the nation’s largest health systems and physician groups. Lumeris equips these partners with cutting-edge technology and streamlined care delivery processes, enabling them to achieve remarkable improvements in both healthcare quality and cost-effectiveness.

Through an innovative shared risk model that integrates essential tools, capabilities, and expertise, Lumeris ensures that its provider partners can confidently address both current and future value-based care requirements. Recently acknowledged by the Healthcare Technology Report for its outstanding software, exclusively accessible to Lumeris’ partners, the company also proudly oversees Essence Healthcare, the highest-rated Medicare Advantage plan in the industry, consistently earning a 5-star rating from CMS over the past three years.

Lumeris stands as a pioneer in the transformation of value-based care, leveraging technology-driven capabilities to establish a comprehensive care system that aligns with the expectations of every healthcare provider for their own family. As a trusted partner, Lumeris engages in collaborative ventures with premier health systems and physician practices across the nation, sharing in the risks and operational duties necessary to implement tailored, highly effective value-based care models for diverse populations.

“Our proven track record in enabling health systems and physician groups to manage all value-based populations, including Medicare Advantage, Traditional Medicare, Commercial, and Medicaid, has consistently delivered high-quality outcomes while effectively managing the total cost of care,” said Mike Long, Chairman and CEO of Lumeris. “This recent investment will further enable us to meet the growing demand from our provider partners to adopt value-based models.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Value-Based Care

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |